Royal Bank of Canada is a leading financial services institution that provides a wide range of banking and financial solutions to individuals, businesses, and institutions. The bank offers personal and commercial banking services, wealth management, investment banking, and capital markets services. With a robust network of branch locations and digital platforms, it aims to meet the diverse needs of its clients while focusing on innovation and customer service. Royal Bank of Canada is committed to enhancing the financial well-being of its customers and leveraging its expertise to support economic growth in the communities it serves. Read More
Shares of aircraft leasing company FTAI Aviation (NASDAQ:FTAI) fell 5.1% in the afternoon session after the stock continued to pull back, amid profit taking, as the company reported mixed third-quarter results that saw its profit per share fall short of analyst expectations.
Shares of data protection software company Commvault (NASDAQ:CVLT) fell 6.9% in the afternoon session after the company's stock fell as negative sentiment persisted from its second-quarter earnings report and analysts lowered their price targets. The decline extended a sharp drop from the previous trading session, which occurred after the data protection company reported its financial results. While Commvault's revenue grew 18% year-over-year to $276.2 million, beating expectations, its earnings did not meet forecasts. The company posted an adjusted earnings per share of $0.91, which was just shy of the $0.94 Wall Street had hoped for. Investors focused on the profitability miss, suggesting the company's growth was less profitable than anticipated. Adding to the pressure, analysts at both Cantor Fitzgerald and RBC lowered their price targets on the stock, reinforcing investor concerns following the earnings announcement.
Royal Bank of Canada (RY) stock shows strong technical momentum and a high-quality consolidation pattern, signaling a potential breakout for investors.
The stocks in this article are all trading near their 52-week highs.
This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Shares of mobile app technology company AppLovin (NASDAQ:APP) jumped 5.3% in the afternoon session after Deutsche Bank initiated coverage of the mobile adtech company with a 'buy' rating.
Seaport Capital Club was founded by Jonathan Golub. The club is currently led by an entrepreneurial leadership team and guided by an advisory board composed of seasoned industry professionals and top equity research analysts. Our vision is transformative, aligning with our ambitious spirit and our ability to adapt when market conditions present opportunities.
New York, NY – October 23, 2025 – Royal Bank of Canada (RBC) Capital has recalibrated its outlook for telecommunications giant AT&T (NYSE: T), lowering its price target while maintaining an "Outperform" rating. This adjustment, coming on the heels of AT&T's mixed third-quarter 2025 earnings report, has injected a fresh
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
RBC Capital initiates coverage on Deere & Company with an Outperform rating and $542 price target, citing tech-enabled agriculture and strong EPS growth prospects through 2026.
Shares of residential solar energy company Sunrun (NASDAQ:RUN) jumped 4.4% in the afternoon session after analysts at UBS and Citigroup provided favorable updates on the company.
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced the expiration at 5 p.m. ET of 53,147 warrants (originally 3,454,543 pre-reverse-split warrants) issued to hedge funds and investment funds as part of a 2020 financing, marking the final tranche of such warrants. The Company also reaffirmed Oct. 27, 2025 as the record date for the distribution of contingent value rights (“CVRs”) to Class B Subordinate Voting Shareholders on a one-for-one basis, entitling holders to a potential pro rata share of 10%–50% of any net proceeds from Quantum BioPharma’s $700 million litigation against CIBC World Markets, RBC Dominion Securities, and others.
